Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect
about
sameAs
Anti-cancer activity of new designer hydrogen sulfide-donating hybridsNitric oxide in cancer metastasisEvidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosisChemoprevention of colorectal cancerSilencer of death domains controls cell death through tumour necrosis factor-receptor 1 and caspase-10 in acute lymphoblastic leukemiaAnti-Inflammatory Agents for Cancer Therapy.Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stressThe nitric oxide prodrug JS-K is effective against non-small-cell lung cancer cells in vitro and in vivo: involvement of reactive oxygen species.Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirinGT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.Methyl 2-[2-(2,6-dichloro-4-nitro-anilino)-3,5-dinitro-phen-yl]acetate.NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals.Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) miceNitric oxide and nursing: a review.Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.Positional isomers of aspirin are equally potent in inhibiting colon cancer cell growth: differences in mode of cyclooxygenase inhibition.Nitric Oxide-Releasing Hybrid Drugs Target Cellular Processes Through S-Nitrosylation.Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferationChemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death.NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.NO-Donating NSAIDs, PPARdelta, and Cancer: Does PPARdelta Contribute to Colon Carcinogenesis?NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice.Modulation of carcinogen metabolism by nitric oxide-aspirin 2 is associated with suppression of DNA damage and DNA adduct formation.Chemoprevention for colorectal neoplasia.Aspirin and low-dose nitric oxide-donating aspirin increase life span in a Lynch syndrome mouse model.Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletionThe proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells.A novel NSAID derivative, phospho-ibuprofen, prevents AOM-induced colon cancer in rats.Apoptosis induction by combination of drugs or a conjugated molecule associating non-steroidal anti-inflammatory and nitric oxide donor effects in medullary thyroid cancer models: implication of the tumor suppressor p73.Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.Licofelone-nitric oxide donors as anticancer agents.Anti-inflammatory activity and enhanced COX-2 selectivity of nitric oxide-donating zinc(ii)-NSAID complexes.The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.Studies on the Dual Cytotoxicity and Antioxidant Properties of Berberis vulgaris Extracts and Its Main Constituent Berberine.
P2860
Q26825705-BD0152AB-62B8-466A-9F80-897E7ABB4995Q27022305-6817A01E-8155-406D-93A0-DFC2EF623C6EQ28168893-78567EB9-535A-4928-9A4B-46547B9636EAQ28222931-4DA76B82-098F-4FA1-A03C-F7BD6F6DDD0FQ28541221-06940C51-FD01-4D67-96C1-7E7D7B81B154Q33744129-24D14367-E45D-4B0E-98CF-CD914A317DA7Q34144679-F1AB5372-CBD5-4357-8D9B-CC7149FC2237Q34552077-013B5ABB-587A-4204-931E-07DAA78B6F84Q34574584-2ACC54A5-3FF5-415F-A105-BB74CDB7E07FQ34754579-13F28FA3-25C5-4A26-A342-36397923CD2FQ34999096-E538643B-D5B5-45B5-8383-7DFD4E757281Q36017220-DEACBE21-7CEC-4FBC-B295-E684E842FAF2Q36176425-313128B8-277A-41B0-AB1B-D0E49B23B94DQ36282723-BAD60662-1847-4B38-88A6-111F9F749234Q36689255-8DC3CB34-0D25-4876-A7DC-B74A5FA21C10Q36689462-C496C0BA-ADB9-4B93-805E-DBD4DEE4AB27Q36717145-ED646BC9-09AB-4A1C-B335-A0EF52C9AAFFQ36882663-E3AA6CD3-A5C5-4566-8F46-27E553C55F1AQ37086749-ECE83AD7-E75C-49F0-B2A3-07A14A9D2C9AQ37090409-D672E2E6-D30D-47B5-A14A-3B369F02DCFFQ37166556-C1DC7818-DBD6-46DB-89F3-91F59DE73360Q37182798-B6860EC8-35C3-49ED-B5CE-D97FCAD2C75DQ37185879-584D717F-8243-4CBC-92BC-9C236B372665Q37372211-8D54F0E8-4E14-489F-A294-14E081204A5BQ37427885-135555EC-BB6A-40D9-9F97-92BD8E617B92Q37709953-505F9846-518C-423A-A5F0-A3D4FEF1AAB2Q38108308-AAAEF0E9-7762-49E6-AC77-22881E720BAAQ38132159-BFDB23BA-7F76-4060-B4CB-4D116C71D230Q38695691-AA2731A6-6DA2-4055-81CF-13DC3ABCB5C0Q38843790-8D1AC395-5C78-46B3-84EF-888125699652Q38852006-BB0EA72F-A842-427C-8D97-7FF4439E86C7Q39522892-FE6976D0-8C26-4E8B-87DF-C8F628B834F0Q49010296-29FDF5BD-4FCC-422D-9E3A-AB5056EDB4DAQ49346285-336EF8C2-C879-4CF3-BC3D-809424A7BF2EQ54966006-F7A488D1-D3D3-437A-95E1-3B0B7063CB0D
P2860
Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nitric oxide-donating nonstero ...... tissue type-independent effect
@ast
Nitric oxide-donating nonstero ...... tissue type-independent effect
@en
Nitric oxide-donating nonstero ...... tissue type-independent effect
@nl
type
label
Nitric oxide-donating nonstero ...... tissue type-independent effect
@ast
Nitric oxide-donating nonstero ...... tissue type-independent effect
@en
Nitric oxide-donating nonstero ...... tissue type-independent effect
@nl
prefLabel
Nitric oxide-donating nonstero ...... tissue type-independent effect
@ast
Nitric oxide-donating nonstero ...... tissue type-independent effect
@en
Nitric oxide-donating nonstero ...... tissue type-independent effect
@nl
P2093
P356
P1476
Nitric oxide-donating nonstero ...... tissue type-independent effect
@en
P2093
Basil Rigas
Jennie L Williams
Khosrow Kashfi
Leon L Qiao
Yassir Ryan
Yassir Ryann
P304
P356
10.1124/JPET.102.042754
P407
P577
2002-12-01T00:00:00Z